News Medical on MSN29m
New drug delivery system shows promise for treating choriocarcinoma
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
TransCode reports positive phase 1 trial progress for cancer therapy
BOSTON - TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a micro-cap RNA oncology company with a market capitalization of $6.22 million, has announced the progression of its Phase 1 clinical trial with ...
Researchers develop targeted treatment for aggressive pregnancy cancer
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...